Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q1 EPS of ($0.39), $0.18 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $3.73 million versus the consensus estimate of $4.18 million.

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.